Thomas Flaten
Stock Analyst at Lake Street
(3.08)
# 1,203
Out of 5,148 analysts
36
Total ratings
39.47%
Success rate
5.12%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $8 → $12 | $4.94 | +142.91% | 1 | Feb 17, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $52 | $27.99 | +85.78% | 7 | Jan 12, 2026 | |
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $24.16 | +106.95% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.50 | +260.00% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.37 | +167.06% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $3.23 | +240.56% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $53.59 | +30.62% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $8.09 | +60.69% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $4.40 | +81.82% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.78 | +79.95% | 2 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.64 | +203.03% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $15.75 | +153.97% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $4.21 | +90.02% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $9.06 | -0.66% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $11.77 | +282.33% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.62 | +138.10% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $22.52 | +11.01% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.60 | +239,900.00% | 2 | Nov 17, 2022 |
Insight Molecular Diagnostics
Feb 17, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $4.94
Upside: +142.91%
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35 → $52
Current: $27.99
Upside: +85.78%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $24.16
Upside: +106.95%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.50
Upside: +260.00%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.37
Upside: +167.06%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $3.23
Upside: +240.56%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $53.59
Upside: +30.62%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $8.09
Upside: +60.69%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.40
Upside: +81.82%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.78
Upside: +79.95%
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.64
Upside: +203.03%
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $15.75
Upside: +153.97%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $4.21
Upside: +90.02%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $9.06
Upside: -0.66%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $11.77
Upside: +282.33%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.62
Upside: +138.10%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $22.52
Upside: +11.01%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.60
Upside: +239,900.00%